A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MDMA / methamphetamine, 3,4-methylenedioxymethamphetamine

[Related PubMed/MEDLINE]
Total Number of Papers: 55
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MDMA  (>> Co-occurring Abbreviation)
Long Form:   methamphetamine, 3,4-methylenedioxymethamphetamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Assessment of illicit drugs in wastewater and estimation of drugs of abuse in Adana Province, Turkey. 6-MAM, MDA, MDEA, THC, WBE, WWTPs
2019 Occurrence, removal and environmental risk of markers of five drugs of abuse in urban wastewater systems in South Australia. BE
2019 Rapid detection and quantitation of drugs-of-abuse by wooden-tip electrospray ionization mass spectrometry. THC, WT-ESI-MS
2018 Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE). WBE, WWTPs
2018 Full validation of a method for the determination of drugs of abuse in non-mineralized dental biofilm using liquid chromatography-tandem mass spectrometry and application to postmortem samples. MDA, MDEA, sMRM
2018 Investigating the correlation between wastewater analysis and roadside drug testing in South Australia. ---
2018 Keratinous matrices for the assessment of drugs of abuse consumption: A correlation study between hair and nails. 6-MAM, AMP, BE, COC, COD, EDDP, EME, MOR, MTD
2018 Stimulant and Designer Drug Use: Primary Care Management. ---
2017 An exploratory wastewater analysis study of drug use in Auckland, New Zealand. ---
10  2017 Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market. ATS
11  2017 Prevalence of alcohol and other drugs in injured drivers and their association with clinical outcomes. BACs, MVAs
12  2017 Simultaneous Quantitation of Methamphetamine, Ketamine, Opiates and their Metabolites in Urine by SPE and LC-MS-MS. LC-MS-MS
13  2016 A Book-Type Dried Plasma Spot Card for Automated Flow-Through Elution Coupled with Online SPE-LC-MS/MS Bioanalysis of Opioids and Stimulants in blood. DBS, DPS, Hct, LLOQ, QC, RBC, ULOQ
14  2016 Effects of drugs of abuse on the central neuropeptide Y system. NPY
15  2016 ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen "Amphetamine" and "Methamphetamine/MDMA" Kits. ---
16  2016 Ion mobility spectrometry nuisance alarm threshold analysis for illicit narcotics based on environmental background and a ROC-curve approach. IMS, ROC
17  2016 Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. BBB, BBMVECs, MDPV, METH
18  2016 Profiles and changes in stimulant use in Belgium in the period of 2011-2015. ---
19  2016 Refining correction factors for back-calculation of illicit drug use. THC
20  2016 Temporal trends in drug use in Adelaide, South Australia by wastewater analysis. BZP, MDPV, NPS, PMA, TFMPP
21  2015 Trends in stimulant use in Australia: A comparison of wastewater analysis and population surveys. ---
22  2014 Ozonation of wastewater: removal and transformation products of drugs of abuse. BE, COC, KET, OTPs, OXY
23  2013 Estimating daily and diurnal variations of illicit drug use in Hong Kong: a pilot study of using wastewater analysis in an Asian metropolitan city. ---
24  2013 Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS. ---
25  2013 Substance use initiation: the role of simultaneous polysubstance use. GHB, SPU
26  2013 Wipe sampling of amphetamine-type stimulants and recreational drugs on selected household surfaces with analysis by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. ---
27  2013 [Localization and functions of the D-neuron: significance in pathogenesis of schizophrenia]. AADC, DA, LSD, PEA, TAAR1, TAs, VTA
28  2012 Development of a simultaneous analytical method for selected anorectics, methamphetamine, MDMA, and their metabolites in hair using LC-MS/MS to prove anorectics abuse. ---
29  2011 Abuse liability profile of three substituted tryptamines. 5-MeO-AMT, 5-MeO-DET, DiPT, DMT, DOM, LSD
30  2011 Biotic and abiotic degradation of illicit drugs, their precursor, and by-products in soil. ---
31  2011 Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. UPLC-MS-MS
32  2011 Inhibition of g protein-activated inwardly rectifying k channels by phencyclidine. NMDA
33  2010 Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. MDA, MDEA
34  2010 First nationwide study on driving under the influence of drugs in Switzerland. BAC, DUID, MDEA
35  2010 Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence. ATS, METH
36  2010 [Analytical methods for addictive drugs of abuse]. MP
37  2009 ToF-SIMS application in the visualization and analysis of fingerprints after contact with amphetamine drugs. MA
38  2008 A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain. MAMP
39  2007 Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes. GIRK
40  2007 Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. PTT
41  2006 Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. GC/MS, PPV
42  2005 Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters. DAT, NET, SERT
43  2004 Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'. METH
44  2004 Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. DA, GFAP
45  2004 Polar organic chemical integrative sampling and liquid chromatography-electrospray/ion-trap mass spectrometry for assessing selected prescription and illicit drugs in treated sewage effluents. POCIS, WWTPs
46  2004 The designer drug situation in Ibiza. HMMA, MDA, MDEA, PMA, PMMA
47  2003 Prevalence of illicit drug use in plasmapheresis donors. MDE, US
48  2003 Simultaneous detection of some drugs of abuse in saliva samples by SPME technique. CBD, CBN, DI-SPME, EDDP, GC/MS, HS-SPME, MDEA
49  2002 A field evaluation of five on-site drug-testing devices. DUI
50  2002 Analysis of illicit amphetamine seizures by capillary zone electrophoresis. ---
51  2001 Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides. SERS
52  1999 Distinct features of seizures induced by cocaine and amphetamine analogs. ---
53  1999 Routine analysis of amphetamine class drugs as their naphthaquinone derivatives in human urine by high-performance liquid chromatography. MDA, MDEA
54  1998 Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine, 3-4-methylenedioxyamphetamine, 3,4-methylenedioxyethylam- phetamine, ephedrine, amphetamine and methamphetamine by capillary electrophoresis in uncoated and coated capillaries with native beta-cyclodextrin as the chiral selector: preliminary application to the analysis of urine and hair. MDA, MDE
55  1996 Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. GFAP, i.p, MA